179 related articles for article (PubMed ID: 7327440)
1. The influence of various combinations of plasminogen and streptokinase on fibrinolysis.
Gaffney PJ; Joe F; Rowe EA; Whitaker AN
Haemostasis; 1981; 10(6):304-14. PubMed ID: 7327440
[TBL] [Abstract][Full Text] [Related]
2. The influence of various combinations of plasminogen and streptokinase on fibrinolysis. II. A mechanistic study.
Gaffney PJ; Joe F; Rose EA; Whitaker AN
Haemostasis; 1982; 11(1):2-11. PubMed ID: 7068050
[TBL] [Abstract][Full Text] [Related]
3. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
Summaria L; Boreisha IG; Arzadon L; Robbins KC
Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
[No Abstract] [Full Text] [Related]
4. Zymogen activation in the streptokinase-plasminogen complex. Ile1 is required for the formation of a functional active site.
Wang S; Reed GL; Hedstrom L
Eur J Biochem; 2000 Jul; 267(13):3994-4001. PubMed ID: 10866798
[TBL] [Abstract][Full Text] [Related]
5. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
Sabovic M; Lijnen HR; Keber D; Collen D
Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
[TBL] [Abstract][Full Text] [Related]
6. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
Hare TR; Gardell SJ
Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
[TBL] [Abstract][Full Text] [Related]
7. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards.
Brommer EJ
Thromb Res; 1984 Apr; 34(2):109-15. PubMed ID: 6539513
[TBL] [Abstract][Full Text] [Related]
8. Induction of a sustained fibrinolytic response by BRL 26921 in vitro.
Fears R; Green J; Smith RA; Walker P
Thromb Res; 1985 May; 38(3):251-60. PubMed ID: 3895561
[TBL] [Abstract][Full Text] [Related]
9. A chimeric streptokinase with unexpected fibrinolytic selectivity.
Goldstein J; Matsueda GR; Shaw SY
Thromb Haemost; 1996 Sep; 76(3):429-38. PubMed ID: 8883282
[TBL] [Abstract][Full Text] [Related]
10. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
11. Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone.
Härdig BM; Carlson J; Roijer A
BMC Cardiovasc Disord; 2008 Aug; 8():19. PubMed ID: 18727834
[TBL] [Abstract][Full Text] [Related]
12. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
Andrew M; Brooker L; Leaker M; Paes B; Weitz J
Thromb Haemost; 1992 Sep; 68(3):325-30. PubMed ID: 1440499
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro.
Hauptmann J; Glusa E
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):579-83. PubMed ID: 7578902
[TBL] [Abstract][Full Text] [Related]
14. Deletion of Ile1 changes the mechanism of streptokinase: evidence for the molecular sexuality hypothesis.
Wang S; Reed GL; Hedstrom L
Biochemistry; 1999 Apr; 38(16):5232-40. PubMed ID: 10213631
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) enhances plasma clot lysis in vitro.
Mao SJ; Tucci MA
FEBS Lett; 1990 Jul; 267(1):131-4. PubMed ID: 2142106
[TBL] [Abstract][Full Text] [Related]
16. The thrombolytic activity of streptokinase in the rabbit.
English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
[TBL] [Abstract][Full Text] [Related]
17. [Streptokinase and Staphylokinase: Differences in the Kinetics and Mechanism of Their Interaction with Plasminogen, Inhibitors and Fibrin].
Aisina RB; Mukhametova LI; Gulin DA; Gershkovich KB; Varfolomeyev SD
Bioorg Khim; 2015; 41(5):565-78. PubMed ID: 26762094
[TBL] [Abstract][Full Text] [Related]
18. A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinase.
Wikström K; Mattsson C; Pohl G
Thromb Res; 1993 May; 70(3):217-24. PubMed ID: 8392227
[TBL] [Abstract][Full Text] [Related]
19. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
20. Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.
Zhalyalov AS; Panteleev MA; Gracheva MA; Ataullakhanov FI; Shibeko AM
PLoS One; 2017; 12(7):e0180668. PubMed ID: 28686711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
